Related Experiment Videos
[Growth hormone (GH) test in psychiatric diagnosis]
Annales Medico-Psychologiques
|February 1, 1983
Summary
The human growth hormone (G.H.) response to insulin-induced hypoglycemia does not differentiate between endogenous and neurotic depression. However, a higher G.H. response may predict a faster recovery from depression.
Area of Science:
- Endocrinology
- Neuroscience
- Psychiatry
Context:
- The study investigates the utility of the insulin tolerance test (ITT) in differentiating between subtypes of depression.
- Previous research has explored various physiological markers for depression diagnosis.
Purpose:
- To evaluate the growth hormone (G.H.) response during the insulin tolerance test (ITT) as a diagnostic tool for distinguishing between endogenous and neurotic depression.
- To assess the prognostic value of G.H. response in predicting depression recovery.
Summary:
- In 14 patients, the G.H. response to insulin-induced hypoglycemia (Sachar test) was measured.
- No significant correlation was found between decreased G.H. response and endogenous depression, nor between increased G.H. response and neurotic depression.
- A high G.H. response level appears to be a reliable indicator for predicting a faster course of depression recovery.
Impact:
- This study suggests that the G.H. response to ITT is not a reliable differential diagnostic marker for depression subtypes.
- The findings highlight the potential prognostic value of G.H. response, indicating its utility in predicting treatment outcomes and recovery timelines.
- Further research is warranted to explore the underlying mechanisms and clinical applications of G.H. response in depressive disorders.